Background/Aims: Multiple sclerosis (MS) is an autoimmune disease in the central nervous system associated with demyelination and axonal injury. Astrocyte activation is involved in the pathogenesis of MS and experimental autoimmune encephalomyelitis (EAE), an animal model of MS. This study was designed to find potential lncRNAs in EAE mice and activated astrocytes. Methods: we performed microarray analysis of lncRNAs from the brain tissues of EAE mice and primary mouse astrocytes treated with IL-9(50 ng/ml). 12 lncRNAs were validated through real-time PCR. Gene ontology and KEGG pathway analysis were applied to explore the potential functions of lncRNAs. Results: Differentially expressed 3300 lncRNAs and 3250 mRNAs were in the brain tissues of EAE mice, and 3748 lncRNAs and 3332 mRNAs were in activated astrocytes. Notably, there were 2 co-up-regulated lncRNAs and 3 co-downregulated lncRNAs both in the brain tissues of EAE mice and in activated astrocytes, including Gm14005, Gm12478, mouselincRNA1117, AK080435, and mouselincRNA0681, which regulate the ER calcium flux kinetics, zinc finger protein and cell apoptosis. Similarly, there were 7 mRNAs co-up-regulated and 2 mRNAs co-down-regulated both in vivo and in vitro. Gene ontology and KEGG pathway analysis showed that the biological functions of differentially expressed mRNAs were associated with metabolism, development and inflammation. The results of realtime PCR validation were consistent with the data from the microarrays. Conclusions: Our
Analysis of Long

Introduction
Multiple sclerosis (MS) is a devastating disease of the central nervous system (CNS), and is characterized by activated autoreactive CD4 + T cells that infiltrate into the CNS and mediate inflammation, demyelination, progressive axonal degradation and reactive astrogliosis [1, 2] . MS and its animal model, experimental autoimmune encephalomyelitis (EAE), had initially been thought to be Th1-mediated diseases. Recent studies provide strong evidence that Th17 and Th9 cells also play important roles in the pathogenesis of MS/EAE [3] . IL-9, a signature cytokine produced by Th9 and Th17 cells, is able to amplify Th17 development via a positive feedback loop [3] . Furthermore, IL-9 promotes Th17 cell migration into the CNS through the activation of astrocytes, and blocking IL-9 with neutralizing antibodies ameliorates the EAE [4, 5] .
Astrocytes, the major glial cell type within the CNS, regulate neuronal function and participate in the formation of the blood-brain barrier (BBB) [6] . Furthermore, astrocytes have the capacity to interact with the peripheral immune system by recruiting leukocytes into the CNS [7] . Reactive astrocytosis is a prominent feature in inflammatory condition that occurs during MS and EAE. Experimental evidence suggests that astrocyte activation contributes to a more severe course of MS and EAE characterized by an increased expression of proinflammatory cytokines and chemokines as well as pronounced demyelination [8] [9] [10] . In response to IL-9 treatment, astrocytes increase chemokine production to facilitate T cell recruitment to the CNS [5] . However, the mechanisms by which astrocyte activation contribute to MS/EAE after IL-9 stimulation are not fully understood.
Long non-coding RNAs (lncRNAs) have been defined as transcripts of >200 nucleotides without protein coding capacity. Although genomic studies indicated that approximately twothirds of genomic DNA are pervasively transcribed, less than 2% of mRNAs are ultimately translated into proteins [11, 12] . Based on the position of lncRNA in the genome relative to protein-coding genes, lncRNAs are divided into five categories: sense, antisense, intronic, intergenic and bidirectional [13] . LncRNAs are widely involved in various biological and physiological processes including chromatin remodeling, gene transcription, RNA splicing and protein transport, and directly linked to human diseases including various cancers, and neurological disorders [14] [15] [16] . It has been reported that lncRNAs regulate the gene expression in the immune system and in autoimmune disease [17, 18] . However, the roles of lncRNAs in the process of MS/EAE are still unclear.
In the present study, we analyzed the lncRNA and mRNA expression landscape of the brain tissues from EAE mice and activated astrocytes stimulated by IL-9 in vitro. Our results suggest the potential roles of lncRNAs in regulating astrocyte functions during the process of EAE.
Materials and Methods
Animal ethics statement All experimental procedures described in the present study were conducted according to the Provision and General Recommendation of the Chinese Laboratory Association. The protocol was approved by the Institutional Animal Care and Use Committee of Xuzhou Medical University. The study was approved by the Ethical Committee for Xuzhou Medical University.
Animal model of EAE C57BL/6 mice were obtained from Nanjing University Laboratory Animal Center. Mice were housed in clean plastic cages with the temperature of 25 ± 1 ºC and humidity of 55-65 % and maintained under specific pathogen-free conditions. EAE models were induced according to our previously published procedure [19] . Briefly, 6-to 8-wk-old C57BL/6 female mice randomly divided into two groups (n=10 each group): One was injected by s.c. immunization with 200 µg MOG 35-55 peptide emulsified in complete Freund's adjuvant (CFA, Sigma) containing 5 mg/ml heat-killed mycobacterium tuberculosis (H37Ra strain, Difco). In addition, 200 ng of pertussis toxin (Invitrogen) in PBS was i.p. injected on day 0 and day 2 after MOG 35-55 treatment. Mice were monitored daily for clinical signs of EAE and graded on a scale of increasing severity from 0 to 5: 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of 1 or 2 hind limbs); 3, paraplegia (complete paralysis of 2 hind limbs); 4, paraplegia with fore limb weakness or paralysis; and 5, moribund state or death. Another group was injected with the same volume of PBS, as negative control (NC). Mice were sacrificed after anesthetization by i.p. injection of a mixture of ketamine (120 mg/kg) and xylazine (60 mg/kg).
Primary mouse astrocyte cultures
Primary astrocytes from 0-to 1-day-old C57BL/6 mice were established as previously described [19] . Briefly, the cerebral cortices freed of meninges were dissected, minced and digested. After being washed twice in Dulbecco's Modified Eagle Medium F12 (DMEM/F12) containing 10% fetal bovine serum (FBS) and antibiotics, the cells were filtrated through a 75 µm cell strainer and transferred to culture flasks pre-coated with 1mg/ml poly-L-lysine (Sigma) and cultured at 37˚C with 5% CO 2 . At complete confluence, flasks were shaken on an orbital shaker for 1 h (150 rpm at 37˚C). The cultures were passed for 3 or 4 passages, and glial fibrillary acidic protein (GFAP, astrocytic marker) expression was evaluated via immunofluorescence assay.
Histopathology
Mice were perfusion-fixed with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4) under anesthesia. Brains and spinal cords were removed quickly and further fixed with the same fixation solution overnight at 4 °C. The histological evaluation of brains and spinal cord tissues was performed on 4 μm paraffin-embedded sections stained with hematoxylin and eosin (H&E) or luxol fast blue (LFB) to assess inflammation or demyelination under microscopy. Ultrathin sections of spinal cord tissues were stained with uranyl acetate and lead citrate, and the ultrastructural changes were observed under electron microscopy (EM).
RNA extraction
Total RNA was isolated from the brain tissues of mice and the primary astrocytes according to manufactures instructions. RNA quantity and quality was measured using NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). The RNA integrity of each sample was assessed using standard denaturing agarose gel electrophoresis.
Determination of lncRNA and mRNA profiles in EAE mice and primary astrocytes
The expression profiles of lncRNAs and mRNAs in brain tissues of EAE mice and activated astrocytes were detected using Mouse LncRNA Microarray v2.0 (8 x 60K, Arraystar) by Kangchen Bio-tech (Shanghai, China), which includes 31, 423 lncRNA probes and 25, 376 coding transcripts probes. Microarray assays were also performed using pooled plasma, blood, liver, heart or cell samples [20, 21] . So RNAs from the pooled brain tissues from the control or EAE mice (4 mice in each group) and RNAs from astrocytes (DMEM/ F12 control and IL-9 treatment) underwent microarray analysis. The acquired raw array images were processed by Agilent Feature Extraction software (version 11.0.1.1) and then normalized and analyzed by the GeneSpring GX v12.0 software package (Agilent Technologies). Differentially expressed lncRNAs and mRNAs were then identified through fold-change as well as P values calculated with t-test. The threshold for up-and down-regulation was fold change > 2.0 and p value < 0.05. Afterwards, Hierarchical Clustering was performed to display the distinguishable lncRNAs and mRNAs expression patterns among the samples.
Real-time PCR assay
The total RNA from the brain tissues of mice and cultured astrocytes was extracted with TRIzol reagent (Invitrogen). First-strand cDNAs were generated using PrimeScriptTM RT reagent kit (TaKaRa, Japan), and SYBR Premix Ex TaqTM based on real-time PCR (TaKaRa) were used to analyze the relative expression levels of the selected lncRNAs. The relative gene expression was calculated using the 2 
Results
Inflammatory cell infiltration and severe demyelination in EAE mice
The EAE model has been widely used in the investigation of the mechanisms underlying MS. Here, we also found that MOG 35-55 peptide induced EAE mice showed increasing severity of clinical signs from scale 1 to 4 as time goes on (Fig. 1A) . We then analyzed brain and spinal cord tissues from EAE mice on day 20 after MOG immunization (exhibiting clinical scale 4) by staining with hematoxylin and eosin (HE) and luxol fast blue (LFB), respectively. The results of HE staining showed that the EAE mice brain sections and spinal cord sections developed (Fig. 1D) . Specifically, the myelin sheaths of the EAE mice were ruptured and disintegrated under EM (Fig. 1E ). For astrocyte isolation, at least GFAP + cells occupied 95% in cultured mouse primary astrocytes under Fluorescence microscope (Fig. 1F) .
Differential LncRNA and mRNA expression in the brain tissues from EAE mice and primary mouse astrocytes treated with IL-9
To detect differentially expressed lncRNAs in the brain tissues of EAE mice and activated mouse primary astrocytes, we performed a genome-wide analysis of lncRNA and mRNA expression in the brain tissues of EAE mice (clinical scale 1 and scale 4) and matched NC mice. Meantime, we also analyzed the lncRNA and mRNA expression profiles of non-activated astrocytes (DMEM/F12 control group) and activated astrocytes induced by IL-9 (50 ng/ml, at 3 h and 6 h). We first obtained a graphical overview of the expression signatures of lncRNAs and mRNAs by using scatter plot analyses, which showed that a large number of lncRNAs and mRNAs were differentially expressed in EAE and NC mice ( Fig. 2A and B) . Similarly, many differentially expressed lncRNAs and mRNAs were observed between the activated astrocytes and DMEM control ( Fig. 2C and D) .
We then further analyzed differential expression of lncRNAs and mRNAs with fold change > 2 (the criteria q-value < 0.05) in EAE mice or activated astrocytes compared with NC mice or DMEM control, respectively. Results displayed that 1, 850 lncRNAs and 1, 642 mRNAs were up-regulated, and 1, 450 lncRNAs and 1, 608 mRNAs were down-regulated in the brain tissues of EAE mice (Fig. 3A) . Meanwhile, 1, 584 lncRNAs and 1, 435 mRNAs were up-regulated, and 2, 164 lncRNAs and 1, 897 mRNAs were down-regulated in the astrocytes stimulated by IL-9 stimulation for 3 h and 6 h (Fig. 3 B) . Notably, there were 2 lncRNAs co-up-regulated and 3 lncRNAs co-down-regulated both in the brain tissues from EAE mice and in the activated Similarly, there were 7 mRNAs coup-regulated and 2 mRNAs co-down-regulated both in the brain tissues from EAE mice and in activated astrocytes (Table3; Fig. 3E and F). The list of the top 20 differentially expressed lncRNAs in vivo and in vitro identified by microarray analysis is shown in Table  4 -7. Furthermore, the top 20 up-regulated and downregulated mRNA transcripts in vivo and in vitro are displayed in Table 8 -11, respectively. Importantly, some inflammatory cytokines, including CXCL10 (IP-10), CCL2, CXCL2 and TNF were detected in the up-regulated mRNAs in vivo (clinical scale 1 and scale 4, Table  8 ) or in vitro (at 3 h and 6 h induced by IL-9, Table 10 ). These data suggest that MS/EAE is associated with the changes of lncRNAs and mRNAs in the brain tissues and the activated astrocytes.
Validation of the microarray data using real-time PCR
To further validate the accuracy of microarray data, we randomly selected 12 lncRNAs from the differentially expressed lncRNAs, including 6 that were co-up-regulated (ENSMUST00000119467, AK033297, ENSMUST00000119913, ENSMUST00000075251, ENSMUST00000062533 and ENSMUST00000137239) and 6 co-down-regulated (ENSMUST00000156666, ENSMUST00000145143, ENSMUST00000134472, uc008rso.1, uc008aid.1 and ENSMUST00000149952), and detected their expression through real-time PCR assay. As shown in Fig. 4A , ENSMUST00000119467, AK033297 and ENSMUST00000119913 expression were significantly increased, and ENSMUST00000156666, 
ENSMUST00000145143
and ENSMUST00000134472 expression were significantly decreased in the brain tissues of EAE mice with clinical scale 1 and scale 4, compared with NC control. The expression levels of the ENSMUST00000075251, ENSMUST00000062533 and ENSMUST00000137239 were markedly up-regulated, and uc008rso.1, uc008aid.1, ENSMUST00000149952 were significantly down-regulated in activated astrocytes stimulating with IL-9 for 3 h and 6 h, compared with DMEM control (Fig. 4B) . Overall, these results confirmed the accuracy of microarray data obtained from analysis of pooled samples.
Class distribution of changed lncRNAs
According to the relative location of lncRNA to coding genes, we analyzed class distribution of differentially co-expressed LncRNAs. Among the co-expressed lncRNAs in the brain tissues of EAE mice with clinical scale 1 and scale 4, intergenic lncRNAs were the largest category along with 270 upregulated and 150 down-regulated lncRNAs. Secondly, among antisense lncRNAs 80 were up-regulated and 57 were down-regulated. Thirdly, among sense lncRNAs 67 were upregulated and 20 were down-regulated. Bidirectional lncRNAs were the smallest The expressions of lncRNA ENSMUST00000119467, AK033297 and ENSMUST00000119913 were significantly increased in the brain tissues of EAE mice with clinical scale 1 and in scale 4, meanwhile, ENSMUST00000156666, ENSMUST00000145143 and ENSMUST00000134472 expression were obviously decreased in EAE mice. **P<0.01, ***P<0.001 vs NC (n = 3 mice per group). (B) The expressions of lncRNA ENSMUST00000075251, ENSMUST00000062533 and ENSMUST00000137239 were significantly up-regulated in activated astrocytes stimulated by IL-9 for 3 h and 6 h, while uc008rso.1, uc008aid.1, ENSMUST00000149952 were markedly down-regulated in activated astrocytes. *P<0.05, **P<0.01, ***P<0.001 vs DMEM. Error bars represent means ± SD. category including 32 up-regulated and 9 down-regulated lncRNAs (Fig. 5A) . Similarly, as shown in Fig. 5B , among the coexpressed lncRNAs in the activated mouse primary astrocytes stimulated with IL-9 for 3 h and 6 h, intergenic lncRNAs were still the largest category, including 61up-regulated and 83 down-regulated lncRNAs. The other differentially co-expressed lncRNAs included 57 antisense lncRNAs (17 up-regulated and 40 down-regulated), 30 sense lncRNAs (9 up-regulated and 21 down-regulated), and 17 bidirectional lncRNAs (5 up-regulated and 12 downregulated).
Go and KEGG pathway analysis
To further explore potential molecular mechanism in MS, we ran GO and KEGG Pathway analysis of differentially expressed genes in the brain tissues of EAE mice and activated astrocytes. GO analysis indicated that differentially co-up-regulated transcripts were biological regulation, metabolism regulation and biological process regulation in the brain tissues of EAE mice and activated astrocytes (Fig. 6A and  B) . Furthermore, differentially co-down-regulated genes were mainly associated with cell development in the brain tissues of EAE mice and activated astrocytes (Fig. 6C and D) . Cell
KEGG Pathway analysis showed that 40 pathways were significantly enriched among differentially expressed genes. Co-up-regulated genes in the brain tissues of EAE mice with clinical scale 1 and scale 4 were related to glutamatergic synapases, calcium signaling pathways, retrograde endocannabinoid signaling, adherens junctions, leukocyte transendothelial migration and so on (Fig. 7A) . The co-down-regulated genes in EAE mice were involved in the renin-angiotensin system, African trypanosomiasis, malaria, neuroactive ligand-receptor interaction, etc (Fig. 7B) . Similarly, KEGG Pathway results indicated that the co-up-regulated genes in the activated astrocytes stimulated by IL-9 for 3 h and 6 h were involved in PI3K-Akt signaling pathway, focal adhesion, adherens junctions, regulation of actin cytoskeleton, etc (Fig. 7C) . Furthermore, the co-down-regulated genes in the activated astrocytes were involved in neuroactive ligand-receptor interaction, glycine, serine and threonine metabolism, retrograde endocannabinoid signaling, renin-angiotensin system, etc (Fig. 7D) .
Discussion
MS/EAE is a chronic autoimmune disease of the central nervous system with inflammation, demyelination and axon degradation. Many studies have demonstrated that the blockade of proinflammatory cytokines production in astrocytes can attenuate the damage of MS/EAE [19] [20] [21] .
Over the past decades, the molecular mechanisms underlying MS have been extensively studied. However, our understanding of the pathophysiological process of MS is still incomplete. In recent years, lncRNAs have received much attention in human diseases. Aberrant expression or function of lncRNAs have been linked to cancer, neurological disorders, and hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome [18, 22, 23] . Moreover, lncRNAs are important regulators of immune cells differentiation and function, eg. T cells, dentritic cells, B cells, macrophages and NK cells [24] . Emerging evidence indicates that lncRNAs not only participate in autoimmune diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and psoriasis [25] [26] [27] , but also play important roles in CNS development, homeostasis, stress responses, and plasticity [28] . Recent work points to the role of lncRNAs in oligodendrocyte precursor cell (OPC) differentiation from neural stem cells (NSCs), myelination and remyelination in the CNS [29, 30] . lncRNA (Malat1) displays Table 11 . Top 20 overlapped and down-regulated mRNAs in mouse astrocytes stimulated with IL-9 (50 ng/ml) for 3 h and 6 h in vitro anti-apoptotic and anti-inflammatory roles in microvasculature structure of the brain to reduce ischemic brain injury [31] . However, there is a large gap between the number of existing lncRNAs and their known association with a particular molecular or cellular function in MS/EAE. To date, the functional characterization of lncRNAs during the EAE progression and astrocyte activation has not been carried out systematically. In the present study, we explored the expression profiles of lncRNAs and mRNAs both in the brain tissues of EAE mice and in IL-9-induced astrocytes, analyzed the co-expression of lncRNAs in vivo and in vitro, and inferred their characteristics and possible relations with protein-coding genes. There were 1, 850 up-regulated lncRNAs and 1, 642 up-regulated mRNAs in the brain tissues of EAE mice. Meanwhile 1, 450 lncRNAs and 1, 608 mRNAs were down-regulated. Furthermore, 1, 584 lncRNAs and 1, 435 mRNAs were up-regulated, and 2, 164 lncRNAs and 1, 897 mRNAs were down-regulated in the astrocytes stimulated by IL-9 for 3 h and 6 h. Notably, there were 2 lncRNAs that differentially co-up-regulated and 3 lncRNAs that differentially co-down-regulated both in the brain tissue of EAE mice and in activated astrocytes. There were 7 mRNAs co-up-regulated and 2 mRNAs co-down-regulated both in the brain tissues from EAE mice and in activated astrocytes. Moreover, real-time PCR were performed to verify part of results in EAE mice and in activated astrocytes, which was consistent with the results of lncRNAs microarray. These altered lncRNAs revealed a close association with the levels of inflammatory cytokines secreted by activated astrocytes and severity of EAE mice, suggesting these lncRNAs might provide novel insight into the molecular basis of MS/EAE.
A number of inflammation-related genes were dramatically co-up-regulated in EAE mice and in activated astrocytes, such as cxcl10 (IP-10), cxcl2, ccl2 and tnf. Furthermore, some mRNAs including complement factor B, Transthyretin, LIM homeobox protein 6, G-protein coupled receptor 84 (Gpr84) and Fatty acid binding protein 4 were also screened out and remarkably increased both in vivo and in vitro (Table 8 and 10), whose functions are unclear in the brain tissue of EAE mice. Further studies are needed to identify whether they are involved in EAE processing.
It has been established that lncRNAs are involved in the regulation of the immune system, including NF-κB signaling, anti-viral response, CD4 + and CD8 + T-cell differentiation and inflammatory response [18] . Based on the GO term enrichment and pathway maps of mRNAs, we found that markedly enriched molecular functions and biological processes of up-regulated gene in EAE mice were mainly involved in metabolism regulation, biological regulation, biological process regulation and inflammation. These findings are consistent with previous studies showing that the infiltration of immune cells and inflammations play an important role in the induction and maintenance of MS/EAE [19] .
Conclusion
In summary, our results revealed that lncRNA transcripts were highly enriched and thousands of lncRNAs were differentially expressed in the brain tissues of EAE mice and in activated astrocytes. These lncRNAs were observed to share intergenic, sense overlap, antisense overlap, or bidirectional mRNAs in genome, which may regulate their related protein-genes expression and play key roles in the pathogenesis of EAE. Further studies on these lncRNAs are required to clarify their molecular and cellular functions and determine whether they can serve as potential therapeutic targets in EAE.
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